Ponatinib in chronic-phase chronic myeloid leukemia patients: Final report from a phase 1 trial Meeting Abstract


Authors: Mauro, M. J.; Cortes, J. E.; Kantarjian, H. M.; Shah, N. P.; Bixby, D. L.; Flinn, I. W.; O'Hare, T.; Rivera, V. M.; Lustgarten, S.; Santillana, S.; Heinrich, M. C.; Druker, B. J.; Deininger, M. W.; Talpaz, M.
Abstract Title: Ponatinib in chronic-phase chronic myeloid leukemia patients: Final report from a phase 1 trial
Meeting Title: 58th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 128
Issue: 22
Meeting Dates: 2016 Dec 3-6
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2016-12-02
Language: English
ACCESSION: WOS:000394452501076
PROVIDER: wos
DOI: 10.1182/blood.V128.22.3063.3063
Notes: Meeting Abstract: 3063 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro